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Abstract
Background: Neural tissue has limited potential to self-renew after neurological damage. Cell therapy using BM-
MSCs (bone marrow mesenchymal stromal cells) seems like a promising approach for the treatment of
neurological diseases. However, the neural differentiation of stem cells influenced by massive factors and
interactions is not well studied at present.
Results: In this work, we isolated and identified MSCs from mouse bone marrow. Co-cultured with CART (0.4 nM)
for six days, BM-MSCs were differentiated into neuron-like cells by the observation of optical microscopy.
Immunofluorescence demonstrated that the differentiated BM-MSCs expressed neural specific markers including
MAP-2, Nestin, NeuN and GFAP. In addition, NeuN positive cells could co-localize with TH or ChAT by double-
labled immunofluorescence and Nissl bodies were found in several differentiated cells by Nissl stain. Furthermore,
BDNF and NGF were increased by CART using RT-PCR.
Conclusion: This study demonstrated that CART could promote the differentiation of BM-MSCs into neural cells
through increasing neurofactors, including BNDF and NGF. Combined application of CART and BM-MSCs may be a
promising cell-based therapy for neurological diseases.
Background
Mesenchymal stem cells (MSCs) are attractive for the
regeneration of damaged tissues in clinical applications,
since they are characterized as undifferentiated cells,
able to self-renew with a high proliferative capacity and
possess mesodermal differentiation potential [1]. Bone
marrow-derived MSCs have great potential as therapeu-
tic agents for neurological diseases, because they are
easily obtained from bone marrow and expand rapidly
in vitro. Moreover, there is a lower risk of rejection
using MSCs compared to other sources of stem cells as
they can be autogenic. It has been held that MSCs can
give rise to osteocytes, chondrocytes, adipocytes, and
neural cells [2,3]. However, current induction methods
obtain a lower percentage of neural differentiation and
consume long induction time.
Cocaine- and amphetamine-regulated transcript
(CART) peptides have emerged as major neurotransmit-
ters and hormones. They are widely distributed in the
CNS and involved in regulating many processes, includ-
ing food intake, the maintenance of body weight and
endocrine functions. Moreover, previous study demon-
strated that CART was up-regulated in the cerebral cor-
tex following focal cerebral ischemia in vivo and in
cultured cortical neurons subjected to oxygen-glucose
deprivation (OGD) in vitro. This regulation led to the
reduction of infarct size and OGD-induced cell death
[4]. Also, CART promoted the survival and differentia-
tion of primary hippocampal neurons by up-regulating
BDNF mRNA expression and protein synthesis [2].
NGF is critical for the survival and maintenance
of sympathetic and sensory neurons. Without it, these
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neurons undergo apoptosis [3]. Nerve growth factor
induces axonal growth including axonal branching and a
bit of elongation [5]. BDNF is the second neurotrophic
factor to be characterized after NGF. They help support
the survival of existing neurons and encourage the
growth and differentiation of new neurons and synapses
[6,7]. Emerging evidence established that growth factors
such as BDNF and NGF are physiological inductors for
neural differentiation of MSCs not only in the MSCs,
recipients but also in the MSCs, co-cultured medium
[8,9].
This study tested the hypothesis that CART could
promote the differentiation of MSCs into neural cells
through increasing neurofactors such as BNDF and
NGF.
Results
1. Identification of mouse MSCs
Firstly, cell morphology was observed daily by phase
contrast invert microscopy. In the early days, individual
adherent cells appeared. Among the adherent cells,
some were fibroblastic in shape and the others were
round with dark centers and transparent peripheries. In
the subsequent days, some fibroblastic cells proliferated.
They gave rise to clones of pure fibroblastic cells, each
of which was composed of several cells. Finally, these
cells were almost completely obscured by the fibroblas-
tic cells (Figure 1B). Fluorescent activated cell sorting
(FACS) analysis demonstrated that the expanded plastic
adherent cells were positive for the mesenchymal stem
cell-associated surface markers CD29, CD44 and CD99,
but negative for the hematopoietic progenitor’s specific
surface maker CD34 (Figure 1A). Thus, the cells used in
this study fulfilled all criterion to be defined as MSCs.
2. Neuronal induction of mouse MSCs treated by CART
2.1 Cell Culture
48-72 h after induction, some cells became shorter. In
addition, the cytoplasm gathered towards the nucleus
and formed the axons and dendrites (Figure 2). Another
3 days later, the majority of cells turned into neuron-
like cells. They had large and round cell bodies with
longer axons similar to the shape of cells induced by
endothelial growth factor (EGF) and basic fibroblast
grow factor (bFGF). The uninduced group remained in
fiber-like cells (Figure 2).
2.2 Immunofluorescence Assay of neural marker proteins
MSCs treated or not treated by CART were prepared
for immunofluorescence analysis by antibodies against
the neural precursor Nestin (green, Figure 3A), the mar-
kers of neurons MAP-2 (red, Figure 3C) and NeuN
(green, Figure 3B), and the marker of astrocytes GFAP
(green, Figure 3D). Quantification of immunofluores-
cence staining from three independent experiments
revealed that Nestin, MAP-2, GFAP and NeuN were
25.4 ± 2.1%, 30.8 ± 4.7%, 20.5 ± 2.5%, 32.1 ± 2.3% of all
cells in 3 days and 47.1 ± 1.9%, 41.2 ± 3.1%, 21.3 ±
2.2%, 40.3 ± 2.7% in 6 days (Table 1), respectively. A
similar rate of conversion was induced by EGF/bFGF,
with 27.1 ± 2.0%, 29.3 ± 3.7%, 11.4 ± 2.6%, 31.1 ± 2.9%
in 3 days and 37.1 ± 2.9%, 33.2 ± 3.0%, 14.8 ± 4.2%,
39.3 ± 3.8% in 6 days. Only a trace amount of MSCs in
the untreated group expressed low levels of Nestin (8.2
± 2.2% in 3 days, 13.1 ± 3.0% in 6 days) but no MAP-2,
GFAP or NeuN.
2.3 Function of these differentiated cells
To investigate the function of differentiated neurons,
ChAT (specific surface expression in cholinergic neu-
rons) and TH (marker of dopaminergic neurons) were
detected by immunofluorescence. Results showed that a
few NeuN positive cells co-expressed ChAT (Figure 4A)
or TH (Figure 4B). The MSCs in the control and the
growth factor-treated groups hardly expressed either of
them. Also, we carried out the Nissl stain to look for
Nissl bodies among the MSCs with CART for 6 days.
We found that Nissl bodies existed as dark blue parti-
cles in the cytoplasm of several differentiated MSCs
(Figure 4C). No similar structure was detected in con-
trol group. What is more, excitable properties of MSC-
derived neural like cells were detected by whole cell
recording. Voltage-gated potassium current and voltage-
gated calcium current were elicited in CART treated
MSCs (Additional file 1).
3. CART up-regulated neurofactors BDNF and NGF
In addition to immunofluorescence assay, the neural
specific RNA transcripts BDNF and NGF were amplified
by RT-PCR. For each marker, the RNA extracts of
MSCs were used as controls. This study showed that
BDNF and NGF were highly induced on 6 days after
CART treatment. Compared to the control group, the
amount of BDNF was 1.68 folds (p > 0.05) and 2.45
folds (p < 0.05) higher with the incubation of CART 3
days and 6 days. NGF was also higher with the incuba-
tion of CART, with 1.05 fold of control group in Day 3
(p > 0.05) and 2.01 folds of control group in Day 6 (p <
0.05). There were no significant differences between
CART treated-group and growth factor treated-group
(Figure 5).
Discussion
In the present study, we thoroughly assessed for the first
time the capacity of CART to enhance the neural differ-
entiation of MSCs. We demonstrated that, when
exposed to CART, MAP-2, GFAP or NeuN positive
cells were traced in the cultured MSCs. Furthermore,
the proposed differentiated neurons not only have the
potency to express ChAT and TH, but also display the
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Nissl bodies in the cytoplasm. In addition, neurotrophic
factors including NGF and BDNF were up-regulated in
CART-treated group. Our results suggest that CART may
promote the differentiation of MSCs in vitro by enhancing
the endogenous expression of NGF and BDNF.
MSCs extracted from mouse bone marrow have great
multiplication potency. Cell-doubling time is 48-72 h
and cells can be expanded in culture for more than 60
doublings [10]. Herein, we isolated BM-MSCs with the
characteristics involving adherence to cell culture plas-
tic, specific surface antigen expression, and multipotent
differentiation which met the criterion defined by the
Mesenchymal and Tissue Stem Cell Committee of the
International Society for Cellular Therapy [11]. Also,
BM-MSCs possess pluripotency defined by their ability
to differentiate into bone, fat, cartilage and muscle
[1,12-14]. Compelling evidences unveiled that MSCs are
competent to break germ layer commitment and differ-
entiate into cells expressing neuroectodermal properties
[15]. Such a capacity opens extensive possibilities for
autologous therapeutic treatments in a variety of neuro-
logical disorders. Also, as there are ethical issues related
to isolating stem cells from fetal tissue and from adults,
alternative sources of neuron-like cells for cell therapy
are necessary. Indeed, a portion of studies indicate that,
in contrast to the primary stem cells, the transplantation
of pre-differentiated stem cells can diminish the risk of
tumogenesis in the host patients [16]. However, current
inducing methods obtain a lower percentage of neuronal
differentiation by a long inducing time [17]. In 2000,
Sanchez-Ramos et al used RA in combination with
BDNF to introduce differentiation of BMSC to neural
phenotypes. NeuN and GFAP positive cells only rank
0.5 and 1% respectively [18]. Likewise, Woodbury et al
found b-mercaptoethanol (BME) can rapidly induce the
transition from MSCs into neurons but not glial cells
[19]. There is also a debate about whether or not the
converted neural phenotyped cells are able to work [20].
This premise provided the impetus to investigate better
and new reagent which can yield functional neuronal
cells at a high rate.
Here we extended our study on the neuroectodermal
conversion of BM-MSCs in vitro by exposure to the
prospective peptide CART. After treatment with CART,
we found that CART could successfully differentiate
MSCs into neural cells in vitro. These cells were
Figure 1 Identification of MSCs in vitro. Identification of BM-MSC in vitro. (A) The fluorescent activated cell sorting analysis showed that the
adherent cells were positive for the well-defined MSC surface markers including CD29, CD44, and CD99, while negative for CD34. CD34
precluded the origination of hematopoietic progenitors. (B) MSCs extracted from the mouse bone marrow presented the fibroblastic shape with
dark centers as well as transparent peripheries by the observation of phase contract invert microscopy (scale bar = 50 uM).
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morphologically similar to neural stem cells. More
importantly, they could express neural progenitor stem
cell marker Nestin and mature glial marker GFAP as
well as mature neuron markers like MAP-2 and NeuN.
It indicated that the protocol of using CART for three
or six days induced significant changes in morphology
and expression of markers of early and mature neural
cell types. Similar with induction rate of bFGF plus
EGF, CART exposure obtained that MAP-2, GFAP and
NeuN expressions were found in 30.8 ± 4.7%, 20.5 ±
2.5%, 32.1 ± 2.3% of all cells in 3 days, and 41.2 ± 3.1%,
21.3 ± 2.2%, 40.3 ± 2.7% in 6 days (Figure 4). However,
the expression of one or even two neuronal proteins
does not prove that the cell bearing these “neuronal
markers” is capable of all the complex functions of a
neuron. It will be important to determine whether these
cells possess functional characteristics of neurons. Sub-
sequently, double-labeled immunofluorescence was per-
formed to calculate the function of the converted cells.
It was intriguing that the differentiated NeuN positive
cells co-expressed ChAT or TH. Our study on excitable
property of MSC-derived neural like cells demonstrated
that the differentiated cells pocess founctional patassium
and cacium channels (Additional file 1). Recent research
discovered that the neuron-like cells differentiated from
BM-MSCs resemble the endogenous neural progenitors
in morphological, immunocytochemical, and functional
characteristics [21]. Another independent investigator
also reported that the transformed BM-MSCs exhibit
both neuron-like biochemical function and some corre-
sponding electrophysiological properties [22].
CART is an endogenous neuropeptide which is widely
distributed in the brain and peripheral nervous system.
It has been well-established that CART can promote the
survival and differentiation of neurons. Some investiga-
tors disclosed that CART has the capability to modulate
the expression of growth factors and neurotrophic fac-
tors, which probably participated in the underlying effect
of CART [23]. Based on this theory, we made an
assumption that neurotrophic factors could be the
bridge between CART and stem cell differentiation. In
order to verify this hypothesis, the amount of NGF and
BDNF was determined by RT-PCR. The result that neu-
rotrophic factors are significant higher in CART treated
group implied CART could promote the endogenous
production of neurotrophic factors. Neurotrophic factors
in cell and tissue culture have been shown to promote
neuronal survival and differentiation and also regulate
the growth of axons and dendrites [24,25]. The presence
of growth factors such as BDNF or NGF in the trans-
plantation or the co-culture experiment are considered
as physiological inductors for neural differentiation of
MSCs [8,9]. MSCs can induce a variety of neuro-regula-
tory proteins in addition to BDNF and b-NGF [26].
Further study demonstrated that the NGF and BDNF
receptor TrkA and TrkB do exist on the surface of
MSCs [27]. Moreover, the TrkB receptor modified by
BDNF may trigger the MAPK signal pathway. This pro-
cess contributes to the maturation and neural differen-
tiation of MSCs [20]. Early studies confirmed that
BDNF+RA (retinoic acid) adult bone marrow stromal
cells can be induced to differentiate into neural cells in
vitro [28]. However, CART stimulated the endogenous
BDNF and NGF expression of MSCs. This stimulation
may imitate the natural physiological pattern. As a
result, we obtained a higher yield rate than in previous
studies. In the hippocampus, BDNF and other neurotro-
phins are expressed from early stage of neuron develop-
ment [29,30]. This process is a prerequisite for the
differentiation of neurons derived from hippocampal pre-
cursor cells in vitro [31-33]. Overall, findings suggest that
the BDNF and NGF enhanced by CART may be the
foundation of stem cell differentiation and maturation.
Conclusion
In summary, we identified CART as a potential neuro-
trophic factor. CART can promote the neural differen-
tiation of BM-MSCs, probably through enhancing the
Figure 2 Morphological change of MSCs with or without the
exposure to CART. Particular changes in morphology happened to
MSCs with the exposure to CART. Similar to the situation of the
bFGF/EGF-treated group, several MSCs incubated with CART for 3
days became shorter and nucleus-convergent. They subsequently
evolved to display round cell bodies with long axons in 6 days. In
the control group, mesenchmal stem cells nearly kept stable in the
appearance within the 6 days of, observation (scale bar = 50 uM).
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endogeneous expression of neurotrophic factors. Com-
bined our previous studies [4,34], this study further con-
firmed the benefitial role of CART in the central
nervous system. Besides the protective effect on neurons
through complicated interaction with immunology and
inflammation, CART also contributes to neuronal cells
differentiation and generation. In the future, CART pre-
treatment may become an attractive and implemental
method in stem cell therapy for neurological disease.
Methods
Experimental animals and CART
Kunming mice (three-week old; (20 ± 2) g) were from
the animal center of the Nanjing University of China.
All mice were housed under a 12-hour light/dark cycle
with food and water provided. The Animal Care and
Use Committee of the Nanjing University approved all
mouse protocols. CART was from Phoenix Pharmaceu-
ticals, Inc. (USA).
MSCs isolation, purification and culture
Mice were killed by cervical dislocation, and bone mar-
row samples were collected from tibias and femurs for
Figure 3 Differential spectrum of MSCs determined by Immunofluorescence. Nestin, GFAP, MAP-2 and NeuN were involved to detect
neural progenitors, glial cells, and mature neurons. In the CART treated group (A), the percentage of Nestin (green) positive cells occupied 25.4
± 2.1% in Day 3 and 47.1 ± 1.9% in Day 6. (B) The NeuN (green) positive rate was 32.1 ± 2.3% in 3 days and 40.3 ± 2.7% in 6 days. The
differentiation ratio resembled that of bFGF/EGF. (C) MAP-2 (red) was detected in 30.8 ± 4.7% and 41.2 ± 3.1% of all cells in Day 3 and Day 6.
(D) GFAP (green) ranks 20.5 ± 2.5% in 3 days and 21.3 ± 2.2% in 6 days. The converted rate resembled that of bFGF/EGF. The untreated group
was used as a control..
Table 1 Differential spectrum of MSCs determined by
Immunofluorescence
Nestin MAP-2 GFAP NeuN
3d CON 8.2 ± 2.2% 2.7 ± 0.8% 1.4 ± 0.3% 3.1 ± 1.2%
CART 25.4 ± 2.1%* 30.8 ± 4.7%* 20.5 ± 2.5%* 32.1 ± 2.3%*
B+E 27.1 ± 2.0% 29.3 ± 3.7% 11.4 ± 2.6% 31.1 ± 2.9%
6d CON 13.0 ± 3.0% 2.9 ± 1.0% 1.8 ± 0.5% 3.6 ± 1.1%
CART 47.1 ± 1.9%* 41.2 ± 3.1%* 21.3 ± 2.2%* 40.3 ± 2.7%*
B+E 38.3 ± 2.9% 33.2 ± 2.8% 14.8 ± 4.2% 39.3 ± 3.8%
* p < 0.05 versus control group
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MSCs. MSCs were isolated according to the method
described by Pittenger et al [1]. Mononuclear cells were
resuspended in Dulbecco’s Modified Eagle’s Medium
(DMEM, Gibco, USA), 20% fetal bovine serum (FBS,
Sigma, USA), 100 U/ml penicillin, and 100 μg/ml strep-
tomycin. About 1 × 106 cells were plated into 25 cm2
flasks (Corning, USA) and incubated at 37°C with 5%
CO2 and 95% relative humidity. The medium was first
changed after 72 hours and then every 3 to 4 days
thereafter. When the cultures reached approximately
90% of confluence, MSCs were recovered by the addi-
tion of 0.25% trypsin-ethylenediamine tetraacetic acid
(EDTA) solution (Invitrogen, USA) and replated into
passage culture at 1:3. The purity of MSCs was over
95% after 20 days from initial seeding.
Characterization of isolated MSCs
MSCs have the following characteristics: adherence to
tissue culture plastic and several relatively specific cell
surface markers [11]. The morphology of plastic adher-
ent cells were monitored by an inverse microscope
(TS100, Nikon, Japan). Cell surface molecules was ana-
lyzed on passage 3 cultures of MSCs using flowcytome-
try and the following procedures. Cells were detached
Figure 4 Founctional test of the differentiated MSCs. Cholinergic neurons and dopaminergic neurons were investigated by double labeled
immunofluorescence with the antibodies against ChAT (green) and NeuN as well as TH (green) and NeuN (red) with the purpose of finding
founctional neurons. NeuN positive cells co-expressed with ChAT (A) or TH (B) in the CART-treated group and the bFGF/EGF-incubated group.
(C) The transferred neurons exhibited cytoplasmic dark blue praticles and light blue nucleus by Nissl stain. MSCs devoid of CART displayed dark
blue nucleus and light blue cytoplasm (scale bar = 50 uM).
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from the flask by incubation with a solution of 0.25%
trypsin-EDTA for 5 min at room temperature. They
were then recovered by centrifugation and washed in
flowcytometry buffer consisting of 2% BSA and 0.1%
sodium azide (Sigma) in PBS. They were separated into
aliquots of 1 × 106 cells. Next, they were incubated
with conjugated monoclonal antibodies, either CD34
and CD44 or CD29 and CD90 (Becton Dickinson,
USA), for 20 min. Washed cells were then incubated
with secondary antibodies (Alexa-594 conjugated don-
key anti-rabbit, 1:50 Jackson, USA) for 20 min in the
dark. After washing, the cells were resuspended in 500
μl PBS and analyzed using a FACSCalibur software
(Becton Dickinson, USA).
Neuronal Induction
Subconfluent passage 3 cultures of MSCs were main-
tained in DMEM/20% FBS.
To initiate neuronal differentiation, the cells were
washed with PBS and transferred to neuronal induction
media composed of DMEM/0.4nM CART (Phoenix
Pharmaceuticals, Inc.) at time ranging from 3 days to 6
days. As a positive control, MSCs were differentiated by
DMEM/10 ug.ml-1EGF/10 ug.ml-1bFGF(Sigma, USA). At
the end of the cultivation period, the cells were photo-
graphed and then fixed with frozen pyruvate for 10 min,
preparing for the immunofluorescence assay. The cells
were also used for RNA extraction and reverse tran-
scription-polymerase chain reaction (RT-PCR) analysis
of neurogenic gene expression.
Immunofluorescence Assay and Nissl stain
MSCs were plated on the matrigel-coated dishes
(FISHER, USA). The MSCs fixed by frozen pyruvate
were permeabilited for 30 min in PBS containing 0.1%
Triton X-100. The samples were incubated with follow-
ing primary antibodies at 4°C overnight: antibodies for
Nestin (1: 50, Sigma, USA), MAP-2 (1:100, Sigma,
USA), GFAP (1:100, Sigma, USA), NeuN (1:100, Sigma,
USA), ChAT (1:50, Sigma, USA), and TH(1: 100,
Singma, USA). Primary antibodies were detected by
using Cy2- or Cy3- conjugated goat anti-rabbit or anti-
mouse secondary antibodies (1: 200, Sigma, USA) for
1 hour at room temperature. After reaction with sec-
ondary antibodies, the cells were stained with 100 nM
DAPI (Sigma, USA) for 15 seconds, then mounted.
Fluorescence-labeled MSCs were viewed and photo-
graphed (AX10, ZEISS, German).
To detect Nissl bodies, differentiated cells were har-
vested and fixed in 4% neutral buffered formalin for 1 h,
and then stained for 30 min with 0.1% Cresyl violet in
room tempreture.
Figure 5 Neurotrophic factors effected by CART. RT-PCR was performed to calculate the endogenous expression of BDNF and NGF in Day 3
and Day 6. In contrast with the control group, the amount of BDNF was 1.68-fold and 2.45-fold higher with the incubation of CART at 3 days
and 6 days. NGF was also higher with incubation of cart, with 1.05-fold of the control group in Day 3 and 2.01-fold of the control group in Day
6. There were no significant differences between CART treated-group and growth factor treated-group. (* p < 0.05 versus control group).
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Real-time quantitative PCR
At 3 or 6 days, post-induction, the MSCs reached
approximately 80% of confluence, and total RNA was
extracted with Trizol (Invitrogen, USA) according to the
manufacturer’s instructions. cDNA was synthesized
from RNA using the AMV reverse transcriptase (Gibco,
USA). Real-time quantitative PCR was performed with a
7500 real-time PCR System (ABI 7500, USA). After
initial denaturation, PCR was carried out for 30 cycles
at 94°C for 45 seconds and 56°C for 45 seconds. Relative
abundance of mRNA was calculated after normalization
to GAPDH ribosomal RNA. The following primers were
designed and used for real-time PCR:
BDNF: forward 5’ ATG CTC AGC AGT CAA GTG
CC 3’, reverse 5’ AGT AAG GGC CCG AAC ATA CG 3’
NGF: forward 5’ AGC CCA CTG GAC TAA ACT TCA
G 3’, reverse 5’ CAA AGG TGT GAG TCG TGG TGC A 3’
Statistical Analysis
Differences among treatment groups were analyzed with
a t-test for two groups (SPSS 13.0, USA). The criterion
for statistical significance was set at P < 0.05. All values
are reported as the mean ± SEM.
Additional material
Additonal File 1: Excitable properties of MSC-derived neural like
cells. (A) Voltage-gated potassium current was evoked by a series of
depolarizing pulses from -100 mV to +50 mV stepping by 10 mV with
interval time of 5 sec. (B) voltage-gated calcium current was elicited by
depolarizing to -40 mV (200 ms) from a holding potential of -80 mV and
then further depolarized to 0 mV (200 ms) with interval time of 5 sec.
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BM-MSC: bone marrow mesenchymal stromal cell; CART: cocaine- and
amphetamine-regulated transcript; OGD: oxygen-glucose deprivation; BDNF:
brain derived neurotrophic factor; NGF: nerve growth factor; bFGF: basic
fibroblast grow factor; EGF: endothelial growth factor; ChAT:
cholineacetyltransferase; TH: tyrosine hydroxylase
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